Viral Hypothesis and Antiviral Treatment in Alzheimer’s Disease

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Current Neurology and Neuroscience Reports

• Publication date

  2018-07-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s11910-018-0863-1PMID 30008124PMCID PMC6450072
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TLR3 Mutations in Adult Patients With Herpes Simplex Virus and Varicella-Zoster Virus Encephalitis

  2017cited by this paper
• Microbes and Alzheimer's Disease.

  2016cited by this paper
• Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management

  2016cited by this paper
• Reactivated herpes simplex infection increases the risk of Alzheimer's disease

  2015cited by this paper
• Herpes simplex infection and the risk of Alzheimer's disease: A nested case‐control study

  2015cited by this paper
• Host entry by gamma-herpesviruses--lessons from animal viruses?

  2015cited by this paper
• Cytomegalovirus infection and risk of Alzheimer disease in older black and white individuals.

  2015cited by this paper
• The combined risks of reduced or increased function variants in cell death pathway genes differentially influence cervical cancer risk and herpes simplex virus type 2 infection among black Africans and the Mixed Ancestry population of South Africa

  2015cited by this paper
• Persistent Infection by HSV-1 Is Associated With Changes in Functional Architecture of iPSC-Derived Neurons and Brain Activation Patterns Underlying Working Memory Performance

  2014cited by this paper
• HSV-1 and Alzheimer’s disease: more than a hypothesis

  2014cited by this paper
• Relationship between herpes simplex virus-1-specific antibody titers and cortical brain damage in Alzheimer’s disease and amnestic mild cognitive impairment

  2014cited by this paper
• Herpes simplex virus type 1 and Alzheimer’s disease: increasing evidence for a major role of the virus

  2014cited by this paper
• Repackaging FDA-approved drugs for degenerative diseases: promises and challenges

  2014cited by this paper
• Assessment of blood–brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review

  2014cited by this paper
• Increase in the IgG avidity index due to herpes simplex virus type 1 reactivation and its relationship with cognitive function in amnestic mild cognitive impairment and Alzheimer's disease.

  2013cited by this paper
• Intracerebral propagation of Alzheimer's disease: Strengthening evidence of a herpes simplex virus etiology

  2013cited by this paper
• Antiviral agents for herpes simplex virus.

  2013cited by this paper
• Antiherpes virus-specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.

  2013cited by this paper
• Propagation of tau pathology in Alzheimer’s disease: identification of novel therapeutic targets

  2013cited by this paper
• A phase 3 trial of semagacestat for treatment of Alzheimer's disease.

  2013cited by this paper
• Susceptibility genes are enriched in those of the herpes simplex virus 1/host interactome in psychiatric and neurological disorders.

  2013cited by this paper
• Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau

  2013cited by this paper
• Cerebrospinal fluid Alzheimer's biomarker profiles in CNS infections

  2013cited by this paper
• Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome

  2013cited by this paper
• Trans-Synaptic Spread of Tau Pathology In Vivo

  2012cited by this paper
• Exposure to herpes simplex virus type 1 and cognitive impairments in individuals with schizophrenia.

  2012cited by this paper
• Additive effects of elevated C-reactive protein and exposure to Herpes Simplex Virus type 1 on cognitive impairment in individuals with schizophrenia.

  2012cited by this paper
• Persistent infection with neurotropic herpes viruses and cognitive impairment

  2012cited by this paper
• Alzheimer's disease plaques and tangles: cemeteries of a pyrrhic victory of the immune defence network against herpes simplex infection at the expense of complement and inflammation-mediated neuronal destruction.

  2011cited by this paper
• Antivirals Reduce the Formation of Key Alzheimer's Disease Molecules in Cell Cultures Acutely Infected with Herpes Simplex Virus Type 1

  2011cited by this paper
• A randomized, double-blind, placebo-controlled trial of valacyclovir prophylaxis to prevent zoster recurrence from months 4 to 24 after BMT

  2011cited by this paper
• Valacyclovir for Herpes Simplex Encephalitis

  2011cited by this paper
• Herpes Simplex Virus Dances with Amyloid Precursor Protein while Exiting the Cell

  2011cited by this paper
• LRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier.

  2011cited by this paper
• HSV-1 promotes Ca2+ -mediated APP phosphorylation and Aβ accumulation in rat cortical neurons.

  2011cited by this paper
• A fas gene polymorphism influences herpes simplex virus type 2 infection in South African women

  2010cited by this paper
• APP Processing Induced by Herpes Simplex Virus Type 1 (HSV-1) Yields Several APP Fragments in Human and Rat Neuronal Cells

  2010cited by this paper
• Valacyclovir neurotoxicity: clinical experience and review of the literature

  2009cited by this paper
• Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases

  2009cited by this paper
• Herpes simplex virus type 1 DNA is located within Alzheimer's disease amyloid plaques

  2009cited by this paper
• Alzheimer's Disease-Specific Tau Phosphorylation is Induced by Herpes Simplex Virus Type 1

  2009cited by this paper
• Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal Function

  2009cited by this paper
• The High Prevalence of Herpes Simplex Virus Type 1 DNA in Human Trigeminal Ganglia Is Not a Function of Age or Gender

  2008cited by this paper
• Apolipoprotein E-ε4 and recurrent genital herpes in individuals co-infected with herpes simplex virus type 2 and HIV

  2008cited by this paper
• Are some cases of psychosis caused by microbial agents? A review of the evidence

  2008cited by this paper
• Seropositivity to Herpes Simplex Virus Antibodies and Risk of Alzheimer's Disease: A Population-Based Cohort Study

  2008cited by this paper
• Association between cognitive functioning, exposure to Herpes Simplex Virus type 1, and the COMT Val158Met genetic polymorphism in adults without a psychiatric disorder.

  2008cited by this paper
• Detection of Herpesvirus DNA in Cerebrospinal Fluid and Correlation with Clinical Symptoms

  2008cited by this paper
• Herpes simplex virus infection causes cellular beta-amyloid accumulation and secretase upregulation.

  2007cited by this paper
• Suppressive therapy versus episodic therapy with oral valacyclovir for recurrent herpes labialis: efficacy and tolerability in an open-label, crossover study.

  2007cited by this paper
• The neurotropic herpes viruses: herpes simplex and varicella-zoster.

  2007cited by this paper
• Effect of Apolipoprotein E on the Cerebral Load of Latent Herpes Simplex Virus Type 1 DNA

  2006cited by this paper
• The Influence of Latent Viral Infection on Rate of Cognitive Decline over 4 Years

  2006cited by this paper
• Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States.

  2006cited by this paper
• Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation*

  2006cited by this paper
• A randomized clinical trial of valacyclovir in multiple sclerosis

  2005cited by this paper
• Herpes simplex virus interferes with amyloid precursor protein processing

  2005cited by this paper
• Olfactory transmission of neurotropic viruses

  2005cited by this paper
• Infection with herpes simplex virus type 1 is associated with cognitive deficits in bipolar disorder.

  2004cited by this paper
• Impact of viral and bacterial burden on cognitive impairment in elderly persons with cardiovascular diseases.

  2003cited by this paper
• Acyclovir Levels in Serum and Cerebrospinal Fluid after Oral Administration of Valacyclovir

  2003cited by this paper
• Association of serum antibodies to herpes simplex virus 1 with cognitive deficits in individuals with schizophrenia.

  2003cited by this paper
• Involvement of Apolipoprotein E in the Hematogenous Route of Herpes Simplex Virus Type 1 to the Central Nervous System

  2002cited by this paper
• A randomized, double-blind, placebo-controlled MRI study of anti–herpes virus therapy in MS

  2002cited by this paper
• Evidence for seeding of beta -amyloid by intracerebral infusion of Alzheimer brain extracts in beta -amyloid precursor protein-transgenic mice.

  2000cited by this paper
• Cognitive Outcome in Acute Sporadic Encephalitis

  2000cited by this paper
• Evidence for Seeding of β-Amyloid by Intracerebral Infusion of Alzheimer Brain Extracts in β-Amyloid Precursor Protein-Transgenic Mice

  2000cited by this paper
• Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy.

  1995cited by this paper
• Induction of beta (A4)-amyloid in primates by injection of Alzheimer's disease brain homogenate. Comparison with transmission of spongiform encephalopathy.

  1994cited by this paper
• Age distribution of latent herpes simplex virus 1 and varicella-zoster virus genome in human nervous tissue.

  1993cited by this paper
• Latent herpes simplex virus type 1 in normal and Alzheimer's disease brains

  1991cited by this paper
• Acyclovir concentrations in serum and cerebrospinal fluid at steady state.

  1989cited by this paper
• Viruses, brain and immunosuppression

  1986cited by this paper
• Cerebrospinal fluid alterations in herpes simplex virus encephalitis.

  1984cited by this paper
• “Limbic Predilection in Alzheimer Dementia: Is Reactivated Herpesvirus Involved?”

  1982cited by this paper

• Recombinant zoster vaccine is associated with a reduced risk of dementia

  2026cites this paper
• Unmasking the hidden catalyst: How infections trigger Alzheimer's disease.

  2026cites this paper
• Herpes zoster vaccination and incident dementia in Canada: an analysis of natural experiments.

  2026cites this paper
• Implications of virus-induced stress granules in tauopathies

  2026cites this paper
• Non-targeted metabolomic profiling of Cistus species and association with anticholinesterase efficacy for Alzheimer's disease: In vitro and in silico evaluation.

  2025cites this paper
• Alzheimer’s Disease Etiology Hypotheses and Therapeutic Strategies: A Perspective

  2025cites this paper
• Herpes Zoster Vaccination and Dementia Occurrence.

  2025cites this paper
• Bibliometric and Visual Analysis of Alzheimer’s Disease and Herpes Simplex Virus Type 1 Infection Between 1990 and 2024

  2025cites this paper
• Could the shingles vaccine help to prevent dementia?

  2025cites this paper
• A natural experiment on the effect of herpes zoster vaccination on dementia

  2025cites this paper
• Effect of herpes zoster vaccination on dementia occurrence: A quasi-experimental study in Australia

  2025cites this paper
• Valacyclovir Treatment of Early Symptomatic Alzheimer Disease: The VALAD Randomized Clinical Trial.

  2025cites this paper
• The effect of shingles vaccination at different stages of the dementia disease course

  2025cites this paper
• From Lab to Clinic: Success Stories of Repurposed Drugs in Treating Major Diseases

  2025cites this paper
• Advancements in Immunity and Dementia Research: Highlights from the 2023 AAIC Advancements: Immunity Conference

  2024cites this paper
• Unveiling the Involvement of Herpes Simplex Virus-1 in Alzheimer’s Disease: Possible Mechanisms and Therapeutic Implications

  2024cites this paper
• An overview on the impact of viral pathogens on Alzheimer's disease.

  2024cites this paper
• Exploring Novel Therapeutic Avenues: Drug Repurposing for Neurodegenerative Movement Disorders.

  2024cites this paper
• The effect of herpes zoster vaccination at different stages of the disease course of dementia: Two quasi-randomized studies

  2024cites this paper
• Sequence of Molecular Events in the Development of Alzheimer’s Disease: Cascade Interactions from Beta-Amyloid to Other Involved Proteins

  2024cites this paper
• Mapping disparities in viral infection rates using highly multiplexed serology

  2024cites this paper
• Periodontitis promotes bacterial extracellular vesicle-induced neuroinflammation in the brain and trigeminal ganglion

  2023cites this paper
• Mechanistic insights into the role of herpes simplex virus 1 in Alzheimer’s disease

  2023cites this paper
• The effect of herpes zoster vaccination on the occurrence of deaths due to dementia in England and Wales

  2023cites this paper
• Causal evidence that herpes zoster vaccination prevents a proportion of dementia cases

  2023cites this paper
• Vaccinium bracteatum Thunb Extract Inhibits HSV-1 Infection by Regulating ER Stress and Apoptosis

  2022cites this paper
• Cerebral organoids for modeling of HSV-1-induced-multiscale neuropathology associated with Alzheimer’s disease and phenotypic rescue

  2022cites this paper
• A reappraisal on amyloid cascade hypothesis: the role of chronic infection in Alzheimer’s disease

  2022cites this paper
• Dual role of the nasal microbiota in neurological diseases-An unignorable risk factor or a potential therapy carrier.

  2022cites this paper
• Cerebral Organoids for Modeling of HSV-1-Induced-Amyloid β Associated Neuropathology and Phenotypic Rescue

  2022cites this paper
• New Drug Design Avenues Targeting Alzheimer’s Disease by Pharmacoinformatics-Aided Tools

  2022cites this paper
• Increased incidence of dementia following herpesvirus infection in the Korean population

  2022cites this paper
• Infectious origin of Alzheimer’s disease: Amyloid beta as a component of brain antimicrobial immunity

  2022cites this paper
• Zika virus infection of mature neurons from immunocompetent mice generates a disease-associated microglia and a tauopathy-like phenotype in link with a delayed interferon beta response

  2022cites this paper
• Author Response: Trajectories of Neurologic Recovery 12 Months After Hospitalization for COVID-19: A Prospective Longitudinal Study

  2022cites this paper
• Multi-pathogen infections and Alzheimer’s disease

  2021cites this paper
• Research on Alzheimer's Disease: Time as a Factor in Anti-Herpes Drug Treating HSV1 Virus and A-ßeta Related Oligomer Plaques

  2021cites this paper
• COVID-19 and Alzheimer’s disease: how one crisis worsens the other

  2021cites this paper
• Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?

  2021cites this paper
• SARS-CoV-2 infection in patients with serious mental illness and possible benefits of prophylaxis with Memantine and Amantadine

  2021cites this paper
• Sleep, circadian rhythm and gut microbiota: alterations in Alzheimer’s disease and their potential links in the pathogenesis

  2021cites this paper
• Viral Involvement in Alzheimer’s Disease

  2021cites this paper
• Participation of Endosomes in Toll-Like Receptor 3 Transportation Pathway in Murine Astrocytes

  2020cites this paper
• Introducing APOA1 as a key protein in COVID-19 infection: a bioinformatics approach

  2020cites this paper
• Environmental Toxins and Alzheimer's Disease Progression.

  2020cites this paper
• Multi-trait association studies discover pleiotropic loci between Alzheimer’s disease and cardiometabolic traits

  2020cites this paper
• Independent and Correlated Role of Apolipoprotein E ɛ4 Genotype and Herpes Simplex Virus Type 1 in Alzheimer’s Disease

  2020cites this paper
• Current Strategies and Novel Drug Approaches for Alzheimer Disease.

  2020cites this paper
• Sildenafil for the Treatment of Alzheimer’s Disease: A Systematic Review

  2020cites this paper
• Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease

  2020cites this paper
• Combinatorial analyses reveal that cellular composition changes have different impact on transcriptomic changes of cell type specific genes in Alzheimer’s Disease brains

  2020cites this paper
• Pharmacological approaches to mitigate neuroinflammation in Alzheimer's disease.

  2020cites this paper
• Antiviral therapy: Valacyclovir Treatment of Alzheimer’s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial

  2020cites this paper
• Rare 3-O-sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake.

  2020cites this paper
• Combinatorial analyses reveal cellular composition changes have different impacts on transcriptomic changes of cell type specific genes in Alzheimer’s Disease

  2020cites this paper
• The biological pathways of Alzheimer disease: a review

  2020cites this paper
• Alzheimer's Gone Viral: Could Herpes Simplex Virus Type-1 Be Stealing Your Memories?

  2020cites this paper
• 3‐ O ‐Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake

  2019cites this paper
• Herpesviral infections and antimicrobial protection for Alzheimer's disease: Implications for prevention and treatment

  2019cites this paper
• A Tug of War: DNA-Sensing Antiviral Innate Immunity and Herpes Simplex Virus Type I Infection

  2019cites this paper
• Neuroprotective Approach of Anti-Cancer Microtubule Stabilizers Against Tauopathy Associated Dementia: Current Status of Clinical and Preclinical Findings

  2019cites this paper
• Precision Medicine and Vaccination of Older Adults: From Reactive to Proactive (A Mini-Review)

  2019cites this paper
• Targeting Neuroin fl ammation as a Therapeutic Strategy for Alzheimer ’ s Disease : Mechanisms , Drug Candidates , and New Opportunities

  2018cites this paper
• Targeting Neuroinflammation as a Therapeutic Strategy for Alzheimer's Disease: Mechanisms, Drug Candidates, and New Opportunities.

  2018cites this paper